Plan your trading with the latest market research on Crypto, Forex, Stocks, and more, from our team of experts.
The end of the year has quite often spelled big gains in the cryptocurrency space, but the final week of…
After crashing on Monday due to high-spreading Omicron cases, stocks rebounded strongly after it was stated that Omicron victims experience…
Stocks posted a negative week with the Nasdaq hitting the biggest loser mark. The tech-heavy benchmark declined nearly 3%, while…
The general sentiment around the cryptocurrency market seems to be heading into negative territory this week. The price of Bitcoin,…
It was not a good week for crypto fans as a massive drop off saw Bitcoin lose 20 percent of…
News of a new “COVID variant of concern” plunged stocks which were already having a lousy week. With them went…
While news around the cryptocurrency market has been mostly positive for the past few weeks, it was hit hard by…
Bitcoin continues to make great leaps forward, breaking new all-time highs through a couple of weeks, but the coin has…
Things have, recently, looked bright for the entire cryptocurrency space with Bitcoin not long off a new all-time high and…
After Bitcoin managed to break its own all-time high and top out at $67,000 things have settled down a little…
It has been a long time coming, but Bitcoin finally managed to break its long-standing all-time high and climb to…
In the growth and development of Bitcoin towards a mainstream financial asset, the desire to have a Bitcoin ETF has…
Bitcoin’s often testy relationship with the SEC is back in the spotlight after the regulatory body looked to be softening…
The battle between the Bitcoin bulls and bears seems to be leaning towards the former as the month of October…
The information provided here is not an invitation to buy or sell products, nor is it an invitation to make an investment or trading strategy. This should not be seen as financial or investment advice of any kind, nor does Prime XBT endorse or guarantee the relevance, timeliness, or accuracy of the information or publications.
Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.
